Full Text of SB0199 103rd General Assembly
SB0199sam001 103RD GENERAL ASSEMBLY | Sen. Sara Feigenholtz Filed: 3/22/2023
| | 10300SB0199sam001 | | LRB103 25368 SPS 59462 a |
|
| 1 | | AMENDMENT TO SENATE BILL 199
| 2 | | AMENDMENT NO. ______. Amend Senate Bill 199 by replacing | 3 | | everything after the enacting clause with the following:
| 4 | | "Section 5. The Nurse Practice Act is amended by changing | 5 | | Section 65-43 as follows: | 6 | | (225 ILCS 65/65-43) | 7 | | (Section scheduled to be repealed on January 1, 2028) | 8 | | Sec. 65-43. Full practice authority. | 9 | | (a) An Illinois-licensed advanced practice registered | 10 | | nurse certified as a nurse practitioner, nurse midwife, or | 11 | | clinical nurse specialist shall be deemed by law to possess | 12 | | the ability to practice without a written collaborative | 13 | | agreement as set forth in this Section. | 14 | | (b) An advanced practice registered nurse certified as a | 15 | | nurse midwife, clinical nurse specialist, or nurse | 16 | | practitioner who files with the Department a notarized |
| | | 10300SB0199sam001 | - 2 - | LRB103 25368 SPS 59462 a |
|
| 1 | | attestation of completion of at least 250 hours of continuing | 2 | | education or training and at least 4,000 hours of clinical | 3 | | experience after first attaining national certification shall | 4 | | not require a written collaborative agreement. Documentation | 5 | | of successful completion shall be provided to the Department | 6 | | upon request. | 7 | | Continuing education or training hours required by | 8 | | subsection (b) shall be in the advanced practice registered | 9 | | nurse's area of certification as set forth by Department rule. | 10 | | The clinical experience must be in the advanced practice | 11 | | registered nurse's area of certification. The clinical | 12 | | experience shall be in collaboration with a physician or | 13 | | physicians. Completion of the clinical experience must be | 14 | | attested to by the collaborating physician or physicians or | 15 | | employer and the advanced practice registered nurse. If the | 16 | | collaborating physician or physicians or employer is unable to | 17 | | attest to the completion of the clinical experience, the | 18 | | Department may accept other evidence of clinical experience as | 19 | | established by rule. | 20 | | (c) The scope of practice of an advanced practice | 21 | | registered nurse with full practice authority includes: | 22 | | (1) all matters included in subsection (c) of Section | 23 | | 65-30 of this Act; | 24 | | (2) practicing without a written collaborative | 25 | | agreement in all practice settings consistent with | 26 | | national certification; |
| | | 10300SB0199sam001 | - 3 - | LRB103 25368 SPS 59462 a |
|
| 1 | | (3) authority to prescribe both legend drugs and | 2 | | Schedule II through V controlled substances; this | 3 | | authority includes prescription of, selection of, orders | 4 | | for, administration of, storage of, acceptance of samples | 5 | | of, and dispensing over the counter medications, legend | 6 | | drugs, and controlled substances categorized as any | 7 | | Schedule II through V controlled substances, as defined in | 8 | | Article II of the Illinois Controlled Substances Act, and | 9 | | other preparations, including, but not limited to, | 10 | | botanical and herbal remedies; | 11 | | (4) prescribing benzodiazepines or Schedule II | 12 | | narcotic drugs, such as opioids, only in a consultation | 13 | | relationship with a physician; this consultation | 14 | | relationship shall be recorded in the Prescription | 15 | | Monitoring Program website, pursuant to Section 316 of the | 16 | | Illinois Controlled Substances Act, by the physician and | 17 | | advanced practice registered nurse with full practice | 18 | | authority and is not required to be filed with the | 19 | | Department; the specific Schedule II narcotic drug must be | 20 | | identified by either brand name or generic name; the | 21 | | specific Schedule II narcotic drug, such as an opioid, may | 22 | | be administered by oral dosage or topical or transdermal | 23 | | application; delivery by injection or other route of | 24 | | administration is not permitted; at least monthly, the | 25 | | advanced practice registered nurse and the physician must | 26 | | discuss the condition of any patients for whom an a |
| | | 10300SB0199sam001 | - 4 - | LRB103 25368 SPS 59462 a |
|
| 1 | | benzodiazepine or opioid is prescribed; nothing in this | 2 | | subsection shall be construed to require a prescription by | 3 | | an advanced practice registered nurse with full practice | 4 | | authority to require a physician name; | 5 | | (4.5) prescribing up to a 120-day supply of | 6 | | benzodiazepines without a consultation relationship with a | 7 | | physician; thereafter, continued prescription of | 8 | | benzodiazepines shall require a consultation with a | 9 | | physician; nothing in this subsection shall be construed | 10 | | to require a prescription by an advanced practice | 11 | | registered nurse with full practice authority to require a | 12 | | physician name; | 13 | | (5) authority to obtain an Illinois controlled | 14 | | substance license and a federal Drug Enforcement | 15 | | Administration number; and | 16 | | (6) use of only local anesthetic. | 17 | | The scope of practice of an advanced practice registered | 18 | | nurse does not include operative surgery. Nothing in this | 19 | | Section shall be construed to preclude an advanced practice | 20 | | registered nurse from assisting in surgery. | 21 | | (d) The Department may adopt rules necessary to administer | 22 | | this Section, including, but not limited to, requiring the | 23 | | completion of forms and the payment of fees. | 24 | | (e) Nothing in this Act shall be construed to authorize an | 25 | | advanced practice registered nurse with full practice | 26 | | authority to provide health care services required by law or |
| | | 10300SB0199sam001 | - 5 - | LRB103 25368 SPS 59462 a |
|
| 1 | | rule to be performed by a physician.
| 2 | | (Source: P.A. 101-13, eff. 6-12-19; 102-75, eff. 1-1-22 .)".
|
|